| PERIOD ENDING | 22-Sep-09 | 2-Jun-09 | 10-Mar-09 | 16-Dec-08 | | Total Revenue | 88,982 | 71,202 | 67,685 | 69,093 | | Cost of Revenue | 79,996 | 63,455 | 60,401 | 62,456 | | | Gross Profit | 8,986 | 7,747 | 7,283 | 6,637 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,062 | 4,671 | 2,221 | 3,308 | | Non Recurring |
-
| (1,329) | (198) | (291) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,924 | 4,405 | 5,260 | 3,620 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 4,924 | 4,405 | 5,260 | 3,620 | | Interest Expense | 532 | 455 | 458 | 499 | | Income Before Tax | 4,393 | 3,950 | 4,802 | 3,122 | | Income Tax Expense | 1,405 | 1,030 | 1,392 | 906 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,988 | 2,920 | 3,410 | 2,216 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,988 | 2,920 | 3,410 | 2,216 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,988 | $2,920 | $3,410 | $2,216 |
|
0.31% Nasdaq 0.00%
Income Statement
